Biological reactivity of polyphenolic-glutathione conjugates

Chemical Research in Toxicology

Volumn 10, Issue 12, 1997, Pages 1296-1313

  Monks, Terrence J ^a   Lau, Serrine S ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHENOL DERIVATIVE; BUTYLATED HYDROXYANISOLE; DOPAMINE; ESTRADIOL; GLUTATHIONE; HYDROQUINONE; METHEMOGLOBIN; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE; POLYPHENOL DERIVATIVE; SEROTONIN; TETRAHYDROISOQUINOLINE DERIVATIVE;

BLOOD BRAIN BARRIER; BLOOD TOXICITY; DRUG CONJUGATION; DRUG TOXICITY; METHEMOGLOBINEMIA; NEPHROTOXICITY; NEUROTOXICITY; OXIDATION; PARKINSON DISEASE; REVIEW;

ANIMALS; BLOOD; BRAIN; FLAVONOIDS; GLUTATHIONE; HUMANS; KIDNEY; PHENOLS; POLYMERS; QUINONES;

EID: 0031446380     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx9700937     Document Type: Review

References (196)

1. Jeftic, L., and Manning, G. (1970) A survey on the electrochemical reduction of quinones. J. Electroanal. Chem. 26, 195-200.
2. Monks, T. J., Hanzlik, R. P., Cohen, G. M., Ross, D., and Graham, D. G. (1992) Contemporary issues in toxicology. Quinone chemistry and toxicity. Toxicol. Appl. Pharmacol. 112, 2-16.
3. Taniguchi, N., Higashi, T., Sakamoto, Y., and Meister, A. (1989) Glutathione Centennial. Molecular Perspectives and Clinical Implications, Academic Press, San Diego, CA.
4. Brown, E. R., Finley, K. T., and Reeves, R. L. (1971) Steric effects of vicinal substituents on redox equilibria in quinonoid compounds. J. Org. Chem. 36, 2849.
5. Chambers, J. Q. (1974) Electrochemistry of quinones. In The Chemistry of the Quinonoid Compounds (Patai, S., Ed.) Part II, pp 737-791, John Wiley and Sons, New York.
6. Kalyanaraman, B., Premovic, P. I., and Sealy, R. C. (1987) Semiquinone anion radicals from addition of amino acids, peptides and proteins to quinones derived from oxidation of catechols and catecholamines. J. Biol. Chem. 262, 11080-11087.
7. Lau, S. S., Hill, B., Highet, R. J., and Monks, T. J. (1988) Sequential oxidation and glutathione addition to 1,4-benzoquinone: Correlation of toxicity with increased glutathione substitution. Mol. Pharmacol. 34, 829-836.
8. Eckert, K.-G., Eyer, P., Somenbichler, J., and Zetl, I. (1990) Activation and detoxication of aminophenols. III. Synthesis and structural elucidation of various glutathione addition products to 1,4-benzoquinone. Xenobiotica 20, 351-361.
9. Eyer, P., Lierheimer, E., and Strosar, M. (1983) Site and mechanism of covalent binding of 4-dimethylaminophenol to human hemoglobin and implications to the functional properties. Mol. Pharmacol. 23, 282-290.
10. Wilson, I., Wardman, P., Lin, T., and Sartorelli, A. C. (1986) One-electron reduction of 2- and 6-methyl-1,4-naphthoquinone bioreductive alkylating agents. J. Med. Chem. 29, 1381-1384.
11. Buffinton, G. D., Ollinger, K., Brunmark, A., and Cadenas, E. (1989) DT-diaphorase-catalysed reduction of 1,4-naphthoquinone derivatives and glutathionyl-quinone conjugates. Biochem. J. 257, 561-571.
12. Hansson, C., Rorsman, H., and Rosengren, E. (1980) 5-S-Cysteinyldopa as a substrate for tyrosinase. Acta Derm. (Stockholm) 60, 399-402.
13. Ito, S., Novellino, E., Chioccara, F., Misuraca, G., and Prota, G. (1980) Copolymerization of dopa and cysteinyldopa in melanogenesis in vitro. Experientia 36, 822-823.
14. Wefers, H., and Sies, H. (1983) Hepatic low-level chemiluminesence during redox cycling of menadione and the menadione-glutathione conjugate: Relation to glutathione and NAD(P)H: quinone reductase (DT-diaphorase) activity. Arch. Biochem. Biophys. 224, 568-578.
15. Brown, P. C., Dulik, D. M., and Jones, T. W. (1991) The toxicity of menadione (2-methyl-1,4-naphthoquinone) and two thioether conjugates studied with isolated renal epithelial cells. Arch. Biochem. Biophys. 285, 187-196.
16. Ross, D., Larsson, R., Norbeck, K., Ryhage, R., and Moldeus, P. (1985) Characterization and mechanism of formation of reactive products formed during peroxidase-catalysed oxidation of p-phenetidine. Mol. Pharmacol. 27, 277-288.
17. Andersson, B., Larsson, R., Rahimtula, A., and Moldeus, P. (1983) Hydroperoxide-dependent activation of p-phenetidine catalyzed by prostaglandin synthase and other peroxidases. Biochem. Pharmacol. 32, 1045-1050.
18. Andersson, B. R., Larsson, A., Rahimtula, A., and Moldeus, P. (1984) Prostaglandin synthase and horseradish peroxidase catalysed DNA binding of p-phenetidine. Carcinogenesis 5, 161-165.
19. Larsson, R., Boutin, J., and Moldeus, P. (1988) Peroxidase-catalysed metabolic activation of xenobiotics. In Metabolism of Xenobiotics (Gorrod, J. W., Oelschlager, H., and Caldwell, J., Eds.) pp 43-50, Taylor and Francis, New York.
20. Potter, D. W., Miller, D. W., and Hinson, J. A. (1986) Horseradish peroxidase-catalysed oxidation of acetaminophen to intermediates that form polymers or conjugate with glutathione. Mol. Pharmacol. 29, 155-162.
21. Wolff, S. P., and Spector, A. (1987) Pro-oxidant activation of ocular reductants. 2 Lens epithelial cell cytotoxicity of a dietary quinone is associated with a stable free radical formed with glutathione in vitro. Exp. Eye Res. 45, 791-801.
22. Rees, J. R., and Pirie, A. (1967) Possible reactions of 1,2-naphthoquinone in the eye. Biochem. J. 102, 853-863.
23. Wells, P. G., Wilson, B., and Lubek, B. M. (1989) In vivo murine studies on the biochemical mechanism of naphthalene cataractogenesis. Toxicol. Appl. Pharmacol. 99, 466-473.
24. Takahashi, N., Schreiber, J., Fischer, V., and Mason, R. (1987) Formation of glutathione-conjugated semiquinones by the reaction of quinones with glutathione; an ESR study. Arch. Biochem. Biophys. 252, 41-48.
25. Rao, D. N. R., Takahashi, N., and Mason, R. P. (1988) Characterization of a glutathione conjugate of the 1,4-benzosemiquinone-free radical formed in rat hepatocytes. J. Biol. Chem. 263, 17981-17986.
26. Monks, T. J., Lau, S. S., Highet, R. J., and Gillette, J. R. (1985) Glutathione conjugates of 2-bromohydroquinone are nephrotoxic. Drug Metab. Dispos. 13, 553-559.
27. Monks, T. J., Highet, R. J., and Lau, S. S. (1988) 2-Bromo-(diglutathion-S-yl)hydroquinone nephrotoxicity. Physiological, biochemical and electrochemical determinants. Mol. Pharmacol. 34, 492-500.
28. Fowler, L. M., Moore, R. D., Foster, J. R., and Lock, E. A. (1991) Nephrotoxicity of 4-aminophenol glutathione conjugate. Human Exp. Toxicol. 10, 451-459.
29. Monks, T. J., and Lau, S. S. (1994) Glutathione conjugation as a mechanism for the transport of reactive metabolites. In Advances in Pharmacology, Vol. 27: Conjugation-Dependent Carcinogenicity and Toxicology of Foreign Compounds (Anders, M. W., and Dekant, W., Eds.) pp 183-210, Academic Press, New York.
30. Monks, T. J., and Lau, S. S. (1994) Glutathione conjugate mediated toxicities. In Handbook of Experimental Pharmacology, Vol. 112: Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity (Kauffman, F. C., Ed.) pp 459-509, Springer-Verlag, Berlin, Heidelberg, Germany,
31. Meister, A., and Tate, S. S. (1980) Glutathione and related γ-glutamyl compounds. Biosynthesis and utilization. Annu. Rev. Biochem. 45, 559-604.
32. Horiuchi, S., Inoue, M., Morino, Y. (1978) γ-Glutamyl transpeptidase. Sidedness of its active site on renal brush-border membrane. Eur. J. Biochem. 87, 429-437.
33. Tate, S. S. (1980) Enzymes of mercapturic acid formation. In Enzymatic Basis of Detoxication (Jakoby, W. B., Ed.) Vol. 2, pp 95-120, Academic Press, Orlando, FL.
34. Lau, S. S., Jones, T. W., Sioco, R., Hill, B. A., Pinon, R. K., and Monks, T. J. (1990) Species differences in renal γ-glutamyl transpeptidase activity do not correlate with susceptibility to 2-bromo-(diglutathion-S-yl)hydroquinone mediated nephrotoxicity. Toxicology 64, 291-311.
35. Lau, S. S., Kleiner, H. E., and Monks, T. J. (1995) Metabolism as a determinant of species susceptibility to 2,3,5-(triglutathion-S-yl)hydroquinone mediated nephrotoxicity. The role of N-acetylation and N-deacetylation. Drug Metab. Dispos. 23, 1136-1142.
36. Mertens, J. J. W. M., Gibson, N. W., Lau, S. S., and Monks, T. J. (1995) Reactive oxygen species and DNA damage in 2-bromo-(glutathion-S-yl)hydroquinone mediated cytotoxicity. Arch. Biochem. Biophys. 320, 51-58.
37. Jeong, J. K., Dybing, E., Søderlund, E., Brunborg, G., Holme, J. A., Lau, S. S., and Monks, T. J. (1997) DNA damage, gadd153 expression, and cytotoxicity in plateau phase renal proximal tubular epithelial cells treated with a quinol-thioether. Arch. Biochem. Biophys. 341, 300-308.
38. Eyer, P., and Kiese, M (1976) Biotransformation of 4-dimethyl-aminophenol: Reaction with glutathione, and some properties of the reaction products. Chem-Biol. Interact. 14, 165-178.
39. Rivera, M. I., Jones, T. W., Lau, S. S., and Monks, T. J. (1994) Early morphological and biochemical changes during 2-bromo-(diglutathion-S-yl)hydroquinone-induced nephrotoxicity. Toxicol. Appl. Pharmacol. 128, 239-250.
40. Jeong, J. K., Stevens, J. L., Lau, S. S., and Monks, T. J. (1996) Quinone-thioether-mediated DNA damage, growth arrest, and gadd153 expression in renal proximal tubular epithelial cells. Mol. Pharmacol. 50, 592-598.
41. Jeong, J. K., Huang, Q., Lau, S. S., and Monks, T. J. (1997) The response of renal epithelial cells to physiological- and chemical-induced growth arrest. J. Biol. Chem. 272, 7511-7518.
42. Ishiguro, S., Saugawara, H., Kusama, M., Yano, S., Shimojima, N., and Sugawara, S. (1976) Glass capillary column gas chromatographic analysis of tobacco and cellulose cigarette smoke. I. Acidic fractions. Sci. Pap. Cent. Res. Inst. Jpn. Tob. Salt Public Corp. 118, 207-211.
43. Florin, I., Rutberg, L., Curvall, M., and Enzell, C. R. (1980) Screening of tobacco smoke constituents for mutagenicity using the Ames' test. Toxicology 18, 219-232.
44. Gocke, E., Wild, D., Eckhardt, K., and King, M.-T. (1983) Mutagenicity studies with the mouse spot test. Mutat. Res. 117, 201-212.
45. Gocke, E., King, M.-T., Eckhardt, K., and Wild, D. (1981) Mutagenicity of cosmetics ingredients licensed by the European Communities. Mutat. Res. 90, 91-109.
46. Hakura, A., Tsutsui, Y., Mochida, H., Sugihara, Y., Mikami, T., and Sagami, F. (1996) Mutagenicity of dihydroxybenzenes and dihydroxynaphthalenes for Ames Salmonella tester strains. Mutat. Res. 371, 292-299.
47. Hakura, A., Mochida, H., Tsutsui, Y., and Yamatsu, K. (1995) Mutagenicity of benzoquinones for Ames Salmonella tester strains. Mutat. Res. 347, 37-43.
48. 1 mice. Food Chem. Toxicol. 30, 737-747.
49. Shibata, M. A., Hirose, A., Tanaka, H., Asakawa, E., Shirai, T., and Ito, N. (1991) Induction of renal cell tumors in rats and mice, and enhancement of hepatocellular tumor development in mice after long-term hydroquinone treatment. Jpn. J. Cancer Res. 82, 1211-1219.
50. Nerland, D. E., and Pierce, W. M. (1990) Identification of N-acetyl-S-(2,5-dihydroxyphenyl)-L-cysteine as a urinary metabolite of benzene, phenol, and hydroquinone. Drug Metab. Dispos. 18, 958-961.
51. Hill, B. A., Kleiner, H. E., Ryan, E. A., Dulik, D. M., Monks, T. J., and Lau, S. S. (1993) Identification of multi-S-substituted conjugates of hydroquinone by HPLC-Coulometric electrode array analysis and mass spectroscopy. Chem. Res. Toxicol. 6, 459-469.
52. Lau, S. S., Peters, M. M., Kleiner, H. E., Canales, P. L., and Monks, T. J. (1996) Linking the metabolism of hydroquinone to its nephrotoxicity and nephrocarcinogenicity. In Biological Reactive Intermediates V. Basic Mechanistic Research in Toxicology and Human Health Risk Assessment (Snyder, R. R., et al., Eds.) pp 267-273, Plenum Press, New York.
53. Liehr, J. G., and Roy, D. (1990) Free radical generation of cycling estrogens. Free Radical Biol. Med. 8, 415-423.
54. Matthews, V. S., Kirkman, H., and Bacon R. L. (1947) Kidney damage in the golden hamster following chronic administration of diethylstilbestrol and sesame oil. Proc. Soc. Exp. Biol. Med. 66, 195-196.
55. Kirkman, H., and Bacon, R. L. (1952) Estrogen-induced tumors of the kidney. 1-Incidence of renal tumors in intact and gonadectomized male golden hamstrer treated with diethylstilbestrol. J. Natl. Cancer Inst. 13, 745-755.
56. Kirkman, H. (1959) Estrogen-induced tumors of the kidney III. Growth characteristics in the Syrian hamster. Natl. Cancer Inst. Monogr. 1, 1-57.
57. Liehr, J. G., Fang, W.-F., Sirbasku, D. A., and Ari-Ulubelen, A. (1986) Carcinogenicity of catechol estrogens in Syrian hamsters. J. Steroid Biochem. 24, 353-356.
58. Martucci, C. P., and Fishman J. (1993) P450 enzymes of estrogen metabolism. Pharmacol. Ther. 57, 237-257.
59. Iverson, S. L., Shen, L., Anlar, N., and Bolton, J. L. (1996) Bioactivation of estrone and its catechol metabolites to quinoidglutathione conjugates in rat liver microsomes. Chem. Res. Toxicol. 9, 492-499.
60. Ball, P., Haupt, M., and Knuppen, R. (1972) Comparative studies on the metabolism of estradiol in the brain, the pituitary and the liver of the rat. Acta Endocrinol. 87, 1-11.
61. Li, S. A., Purdy, R. H., and Li, J. J. (1989) Variations in catechol-O-methyltransferase activity in rodent tissues: possible role in estrogen carcinogenicity. Carcinogenesis 10, 63-67.
62. Monks, T. J., and Lau, S. S. (1992) Toxicology of quinonethioethers. Crit. Rev. Toxicol. 22, 243-270.
63. Butterworth, M., Lau, S. S., and Monks, T. J. (1996) 17β-Estradiol metabolism in hamster liver microsomes. Implications for the catechol O-methyltransferase mediated detoxication of catechol estrogens. Drug Metab. Dispos. 24, 588-593.
64. Butterworth, M., Lau, S. S., and Monks, T. J. (1996) 17β-Estradiol metabolism by hamster liver microsomes. Comparison of catechol estrogen O-methylation with catechol estrogen oxidation and glutathione conjugation. Chem. Res. Toxicol. 9, 793-799.
65. Ball, P., Haupt, M., and Knuppen, R. (1983) Biogenesis and metabolism of catechol estrogens in vitro. In Catechol Estrogens (Merriam, G. R., and Lipsett, M. B., Eds.) pp 91-103, Raven Press, New York.
66. Stalford, A. C., Maggs, J. L., Gilchrist, T. L., and Park, B. K. (1994) Catecholestrogens as mediators of carcinogenesis: Correlation of aromatic hydroxylation of estradiol and its fluorinated analogues with tumor induction in Syrian hamsters. Mol. Pharmacol. 45, 1259-1267.
67. Tsuruda, L. S., Lame, M. W., and Jones, A. D. (1995) Formation of epoxide and quinone protein adducts in B6C3F1 mice treated with naphthalene, sulfate conjugate of 1,4-dihydroxynaphthalene and 1,4-naphthoquinone. Arch. Toxicol. 69, 362-367.
68. Ball, P., Favthmann, E., and Knuppen, R. (1976) Comparative studes on the metabolism of oestradiol-17β and 2-hydroxyoestradiol-17β in man in vitro and in vivo. J. Steroid Biochem. 1, 139-143.
69. Elce, J. S., Bird, C. F., and Chandra, J. (1973) Water soluble products of the estrogens. Bile metabolites of 2-hydroxyestradiol-17β in man. J. Clin. Endocrinol. Metab. 36, 1027-1030.
70. Elce, J. S. (1972) Metabolism of a glutathione conjugate of 2-hydroxyoestradiol-17β in the adult male rat. Biochem. J. 126, 1067-1071.
71. Butterworth, M., Lau, S. S., and Monks, T. J. (1998) 2-Hydroxy-4-glutathion-S-yl-17β-estradiol and 2-hydroxy-1-glutathion-S-yl-17β-estradiol produce oxidative stress and renal toxicity in an animal model of hormone-mediated nephrocarcinogenicity. Carcinogenesis 19, in press.
72. Butterworth, M., Lau, S. S., and Monks, T. J. (1997) Metabolism and mild nephrotoxicity of 17β-estradiol in the golden Syrian hamster. Formation of catechol estrogen glutathione conjugates and implications for 17β-estradiol-mediated nephrocarcinogenicity. Carcinogenesis 18, 561-567.
73. Li, J. J., Gonzalez, A., Banerjee, S., Banerjee, S. K., and Li, S. A. (1993) Estrogen carcinogenicity in hamster kidney: Role of cytotoxicity and cell proliferation. Environ. Health Perspect. 101, 259-264.
74. Gonzalez, A., Oberley, T. O., and Li, J. J. (1989) Morphological and immunohistochemical studies of the estrogen-induced Syrian hamster renal tumor: Probable cell of origin. Cancer Res. 49, 1020-1028.
75. Clayson, D. B., Iverson, F., Nera, E. A., and Lok, E. (1990) The significance of induced forestomach tumors. Annu. Rev. Toxicol. 30, 441-446.
76. Tsuda, H., Fukushima, S., Imaida, K., Sakata, T., and Ito, N. (1984) Modification of carcinogenesis by antioxidants and other compounds. Acta Pharmacol. Toxicol. (Suppl. 2), 125-143.
77. Hasegawa, R., Tiwawech, D., Hirose, M., Takaba, K., Hoshiya, T., Shirai, T., and Ito, N. (1992) Suppression of diethylnitrosamine-initiated preneoplastic foci development in the rat liver by combined administration of four antioxidants at low doses. Jpn. J. Cancer Res. 83, 431-437.
78. Imaida, K., Fukushima, S., Shirai, T., Ohtani, M., Nakanishi, K., and Ito, N. (1983) Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of γ-glutamyl transpeptidase-positive foci development in the rat. Carcinogenesis 4, 895-899.
79. Ito, N., Hirose, M., Fukushima, S., Tsuda, H., Shirai, T., and Tatematsu, M. (1986) Studies on antioxidants: Their carcinogenic and modifying effects on chemical carcinogenesis. Food Chem. Toxicol. 24, 1071-1082.
80. Verhagen, H., Thijssen, H. H. W., Ten Hoor, F., and Kleinjans, J. C. S. (1989) Disposition of single oral doses of butylated hydroxyansiole in man and rat. Food Chem. Toxicol. 27, 151-158.
81. Shibata, M. A., Asakawa, E., Hagiwara, A., Kurata, Y., and Fukushima, S. (1991) DNA synthesis and scanning electron microscopic lesions in renal pelvic epithelium of rats treated with bladder cancer promoters. Toxicol. Lett. 55, 263-272.
82. Tamano, S., Fukushima, S., Shirai, T., Hirose, M., and Ito, N. (1987) Modification by α-tocopherol, propyl gallate and tertiary butylhydroquinone of urinary bladder carcinogenesis in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Cancer Lett. 35, 39-46.
83. Kurata, Y., Fukushima, S., Hasegawa, R., Hirose, M., Shibata, M. A., Shirai, T., and Ito, N. (1990) Structure-activity relations in promotion of rat urinary bladder carcinogenesis by phenolic antioxidants. Jpn. J. Cancer Res. 81, 754-759.
84. Verhagen, H., Schilderman, P. A. E. L., and Kleinjans, J. C. S. (1991) Butylated hydroxyanisole in perspective. Chem.-Biol. Interact. 80, 109-134.
85. Shibata, M. A., Yamada, M., Tanaka, H., and Kagawa, M. (1989) Changes in urine composition, bladder epithelial morphology, and DNA synthesis in male F344 rats in response to ingestion of bladder tumor promoters. Toxicol. Appl. Pharmacol. 99, 37-49.
86. Cummings, S. W., Ansari, G. A. S., Guengerich, F. P., Crouch, L. S., and Prough, R. A. (1985) Metabolism of 3-tert-butyl-4-hydroxyanisole by microsomal fractions and isolated rat hepatocytes. Cancer Res. 45, 5617-5624.
87. Tajima, K., Hashizaki, H., Yamamoto, K., and Mizutani, T. (1992) Metabolism of 3-tert-butyl-4-hydroxyanisole by horseradish peroxidase and hydrogen peroxide. Drug Metab. Dispos. 20 (6), 816-820.
88. Hirose, M., Inoue, T., Masuda, A., Tsuda, H., and Ito, N. (1987) Effect of simultaneous treatment with various chemicals on BHA-induced development of rat forestotnach hyperplasia-complete inhibition by diethylmaleate in a 5-week feeding study. Carcinogenesis 8, 1555-1558.
89. Ito, N., Hirose, M., and Takahashi, S. (1991) Cellular proliferation and stomach carcinogenesis induced by antioxidants. Prog. Clin. Biol. Res. 369, 43-52.
90. Tajima, K., Hashizaki, M., Yamamoto, K., and Mizutani, T. (1991) Identification and structure characterization of S-containing metabolites of 3-tert-butyl-4-hydroxyanisole in rat urine and liver microsomes. Drug Metab. Dispos. 19 (6), 1028-1033.
91. Peters, M. M., Lau, S. S., Dulik, D. M., Murphy, D., van Ommen, B., van Bladeren, P. J., and Monks, T. J. (1996) Metabolism of 2-tert-butylhydroquinone to S-substituted conjugates in the male Fischer 344 rat. Chem. Res. Toxicol. 9, 133-139.
92. Cooper, A. J. L. (1994) Enzymology of cysteine S-conjugate β-lyases. In Advances in Pharmacology, Vol. 27: Conjugation-Dependent Carcinogenicity and Toxicology of Foreign Compounds (Anders, M. W., and Dekant, W., Eds.) pp 71-113, Academic Press, San Diego, CA.
93. Dekant, W., Vamvakas, S., and Anders, M. W. (1994) Formation and fate of nephrotoxic and cytotoxic glutathione S-conjugates: Cysteine conjugate β-lyase pathway. In Advances in Pharmacology, Vol. 27: Conjugation-Dependent Carcinogenicity and Toxicology of Foreign Compounds (Anders, M. W., and Dekant, W., Eds.) pp 115-162, Academic Press: San Diego, CA.
94. Renner, G. (1983) Formation of pentachlorothioanisole from N-acetyl-S-(pentachlorophenyl)cysteine in blood and liver of rats in vivo. Life Sci. 33, 1427-1431.
95. Smith, A. G., and Francis, J. E. (1983) Evidence for the active renal secretion of S-pentachlorophenyl-N-acetyl-L-cysteine by female rats. Biochem. Pharmacol. 32, 3797-3801.
96. Peters, M. M., Jones, T. W., Monks, T. J., and Lau, S. S. (1996) Glutathione conjugates of 2-tert-butylhydroquinone, metabolites of the renal tumor promotertert-butylhydroxyanisole, are toxic to kidney and bladder. Cancer Res. 56, 1006-1011.
97. Lau, S. S., Jones, T. W., Highet, R. J., Hill, B. A., and Monks, T. J. (1990) Differences in the localization and extent of the renal proximal tubular necrosis caused by mercapturic acid and glutathione conjugates of menadione and 1,4-naphthoquinone. Toxicol. Appl. Pharmacol. 104, 334-350.
98. Monks, T. J., Highet, R. J., and Lau, S. S. (1990) Oxidative cyclization, 1,4-benzothiazine formation and dimerization of 2-bromo-3-(glutathion-S-yl)hydroquinone. Mol. Pharmacol. 38, 121-127.
99. Monks, T. J. (1995) Modulation of quinol/quinone-thioether toxicity by intramolecular detoxication. Drug Metab. Rev. 27, 93-106.
100. Fukushima, S., Shibata, M., Kurata, Y., Tamano, S., and Masui, T. (1986) Changes in the urine and scanning electron microscopically observed appearance of the rat bladder following treatment with tumor promoters. Jpn. J. Cancer Res. 77, 1074-1082.
101. Jakoby, W. B., and Stevens, J. (1984) Cysteine conjugate β-lyase and the thiomethyl shunt. Biochem. Soc. Trans. 12, 33-35.
102. Cho, A. K., and Segal, D. S., Eds. (1994) Amphetamine and its Analogues. Psychopharmacology, Toxicology, and Abuse, Academic Press, San Diego, CA.
103. Ricuarte, G., Bryan, G., Strauss, L., Seiden, L., and Schuster, C. (1985) Hallucinogenic amphetamine selectively destroys brain serotonergic nerve terminals. Science 229, 986-988.
104. Commins, D. L., Vosmer, G., Virus, R., Woolverton, W., Schuster, C., and Seiden, L. (1987) Biochemical and histological evidence that methylenedioxymethamphetamine (MDMA) is toxic to neurons in rat brain. J. Pharmacol. Exp. Ther. 241, 338-345.
105. Ricuarte, G. A., DeLanney, L. E., Irwin, I., and Langston, J. W. (1988) Toxic effects of MDMA on central serotonergic neurons in the primate: Importance of route and frequency of drug administration. Brain Res. 446, 165-168.
106. Fuller, R. W. (1976) Pharmacology of p-chloroamphetamine and analogues. Psycho-Pharmacol. Bull. 12, 55-57.
107. Ricaurte, G. A., Martello, A. L., Katz, J. L., and Martello, M. B. (1992) Lasting effects of 3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: Neurochemical observations. J. Pharmacol. Exp. Ther. 261, 616-622.
108. Axt, K. J., Mullen, C. A., and Molliver, M. E. (1992) Cytopathologic features indicitive of 5-hydroxytryptamine axon degeneration are observed in rat brain after administration of D- and L-methylenedioxyamphetamine. Ann. N. Y. Acad. Sci. 648, 245-247.
109. Schmidt, C. J., And Taylor, V. L. (1988) Direct central effects of acute methylenedioxy-methamphetamine on serotonergic neurons. Eur. J. Pharmacol. 156, 121-131.
110. Lin, L., Kumagai, Y., and Cho, A. K. (1992) Enzymatic and chemical demethylenation of (methylenedioxy)amphetamine and (methylenedioxy)methamphetamine by rat brain microsomes. Chem. Res. Toxicol. 5, 401-406.
111. Kumagai, Y., Wickham, K., Schmitz, D. A., and Cho, A. K. (1991) Metabolism of methylenedioxyphenyl compounds by rabbit liver preparations. Biochem. Pharmacol. 42, 1061-106.
112. Midha, K. K., Hubbard, J. W., Bailey, K., and Cooper, J. K. (1978) α-Methyldopamine, a key intermediate in the metabolic disposition of 3,4-methylenedioxyamphetamine in vivo in dog and monkey. Drug Metab. Dispos. 6, 623-630.
113. Lim, H. K., and Foltz, R. L. (1988) In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine in the rat: Identification of metabolites using an ion trap detector. Chem. Res. Toxicol. 1, 370-378.
114. Hiramatsu, M., Kumagai, Y., Unger, S. E., and Cho, A. K. (1990) Metabolism of methylenedioxymethamphetamine: Formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct. J. Pharmacol. Exp. Ther. 254, 521-527.
115. Kumagai, Y., Lin, L., Schmitz, D. A., and Cho, A. K. (1991) Hydroxyl radical-mediated demethylenation of (methylenedioxy)-phenyl compounds. Chem. Res. Toxicol. 4, 330-334.
116. McCann, U. D., and Ricaurte, G. A. (1991) Major metabolites of (±)-3,4-methylenedioxyamphetamine (MDA) do not mediate its toxic effects on brain serotonin neurons. Brain Res. 545, 279-282.
117. Johnson, M., Elayan, I., Hanson, G. R., Foltz, R. L., Gibb, J. W., and Lim, H. K. (1992) Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxyamphetamine, on central serotonergic and dopaminergic systems. J. Pharmacol. Exp. Ther. 261, 447-453.
118. Zhao, Z., Castagnoli, N., Jr., Ricaurte, G. A., Steele, T., and Martello, M. (1992) Synthesis and neurotoxicological evaluation of putative metabolites of the serotonergic neurotoxin 2-(methylamino)-1-[3,4-(methylenedioxy)phenyl]propane [(methylenedioxy)methamphetamine]. Chem. Res. Toxicol. 5, 89-94.
119. Patel, N., Kumagai, Y., Unger, S. E., and Cho, A. K. (1991) Transformation of dopamine and α-methyldopamine by NG-108-15 cells: Formation of thiol adducts. Chem. Res. Toxicol. 4, 421-426.
120. Wolff, J. E. A., Belloni-Olivi, L., Bressler, J. P., and Goldstein, G. W. (1992) γ-Glutamyl transpeptidase activity in brain microvessels exhibits regional heterogeneity. J. Neurochem. 58, 909-915.
121. Kannan, R., Kuhlenkamp, J. F., Jeandidier, E., Trinh, H., Ookhtens, M., and Kaplowitz, N. (1990) Evidence for carrier-mediated transport of glutathione across the blood-brain barrier in the rat. J. Clin. Invest. 85, 2009-2013.
122. Miller, R. T., Lau, S. S., and Monks, T. J. (1996) Effects of 5-(glutathion-S-yl)-α-methyldopamine on dopamine, serotonin, and norepinephrine concentrations following intracerebroventricular administration to male Sprague-Dawley rats. Chem. Res. Toxicol. 9, 457-465.
123. Fujimori, M., and Himwich, H. E. (1969) Electroencephalographic analysis of amphetamine and its methoxy derivatives with reference to their sites of EEG alerting in the rabbit brain. Int. J. Neuropharmacol. 8, 601-613.
124. Stone, D. M., Johnson, M., Hanson, G. R., and Gibb, J. W. (1988) Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 247, 79-87.
125. Brodkin, J., Malyala, A., and Nash, J. F. (1993) Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity. Pharmacol. Biochem. Behav. 45 (3), 647-653.
126. Miller, R. T., Lau, S. S., and Monks, T. J. (1995) Metabolism of 5-(glutathion-S-yl)-α-methyldopamine following intracerebroventricular administration to male Sprague-Dawley rats. Chem. Res. Toxicol. 8, 634-641.
127. Miller, R. T., Lau, S. S., and Monks, T. J. (1997) 2,5-Bis-(glutathion-S-yl)-α-methyldopamine, a putative metabolite of (±)-3,4-methylenedioxyamphetamine, produces long-term decreases in brain serotonin concentrations. Eur. J. Pharmacol. 323, 173-180.
128. Ploemen, J. H. T. M., van Ommen, B., De Haan, A., Venekamp, J. C., and van Bladeren, P. J. (1994) Inhibition of human glutathione S-transferases by dopamine, α-methyldopa and their 5-S-glutathionyl conjugates. Chem.-Biol. Interact. 90, 78-99.
129. Raper, H. S. (1928) The aerobic oxidases. Physiol. Rev. 8, 245-282.
130. Mason, H. S. (1948) The chemistry of melanin. III. Mechanism of the oxidation of dihydroxyphenylalanine by tyrosinase. J. Biol. Chem. 172, 83-99.
131. Mason, H. S. (1955) Phenolase complex. Adv. Enzymol. 16, 105-184.
132. Prota, G. (1988) Progress in the chemistry of melanins and related metabolites. Med. Res. Rev. 8, 525-556.
133. Brightman, M. W., and Reese, T. S. (1969) Junctions between intimately apposed cell membranes in the vertebrate brain. J. Cell Biol. 40, 648-677.
134. Oldendorf, W. H., and Brown, W. J. (1975) Greater number of capillary endothelial mitochondria in brain than in muscle. Proc. Soc. Exp. Biol. Med. 149, 736-738.
135. Schlosshauer, B. (1993) The blood-brain barrier: Morphology, molecules and neurothelin. BioEssays 15, 341-346.
136. Oldendorf, W. H., and Szabo, J. (1976) Amino acid assignment to one of three blood-brain barrier amino acid carriers. Am. J. Physiol. 230, 94-98.
137. Smith, Q. R., Nagura, H., Takada, Y., and Duncan, M. W. (1992) Facilitated transport of the neurotoxin, β-N-methylamino-L-alanine, across the blood-brain barrier. J. Neurochem. 58, 1330-1337.
138. Jackson, M. A., Lyon, J. P., and Siegel, J. (1971) Morphological changes in kidneys of rats exposed to dichloroacetylene-ether. Toxicol. Appl. Pharmacol. 18, 175-184.
139. Reichert, D., Liebaldt, G., and Henschler, D. (1976) Neurotoxic effects of dichloroacetylene. Arch. Toxicol. 37, 23-38.
140. Patel, N., Fullone, J. S., and Anders, M. W. (1993) Brain uptake of S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine, the glutathione and cysteine S-conjugates of the neurotoxin dichloroacetylene. Mol. Brain Res. 17, 53-58.
141. 3H]glutathione in rat brain. Life Sci. 39, 2411-2418.
142. 3H]glutathione in rat central and peripheral tissues. Neurochem. Int. 13, 493-497.
143. Zangerle, L., Cuenod, M., Winterhalter, K. H., and Do, K. Q. (1990) Screening of thiol compounds: Depolarization-induced release of glutathione and cysteine from rat brain slices. J. Neurochem, 59, 181-189.
144. Leslie, S. W., Brown, L. M., Trent, R. D., Lee, Y.-H., Morris, J. L., Jones, T. W., Randall, P. K., Lau, S. S., and Monks, T. J. (1992) Stimulation of N-methyl-D-aspartate receptor-mediated calcium entry into dissociated neurons by reduced and oxidized glutathione. Mol. Pharmacol. 41, 308-314.
145. Liu, Y. F., and Quirion, R. (1992) Modulatory role of glutathione on μ-opioid, substance P/neurokinin 1, and kainic acid receptor binding sites. J. Neurochem. 59, 1024-1032.
146. Kubo, E., Horiuchi, T., Nakamura, A., and Shiomi, H. (1992) Potent antinociceptive effects of centrally administered glutathione and glutathione-disulfide in mice. Jpn. J. Pharmacol. 58 (Suppl. 1), 311.
147. Guo, N., Mcintosh, C., and Shaw, C. (1992) Glutathione; new candidate neuropeptide in the central nervous system. Neuroscience 4, 835-842.
148. Pileblad, E., Magnusson, T., and Fornstedt, B. (1989) Reduction of brain glutathione by L-buthionine sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striaturn. J. Neurochem. 52, 978-980.
149. Strupp, M., Quasthoff, N., Mitrovic, N., and Grafe, P. (1992) Glutathione accelerates sodium channel inactivation in excised rat axonal membrane patches. Eur. J. Physiol. (Pflugers Arch.) 421, 283-285.
150. Shen, X.-M., and Dryhurst, G. (1996) Further insights into the influence of L-cysteine on the oxidation chemistry of dopamine: Reaction pathways of potential relevance to Parkinson's disease. Chem. Res. Toxicol. 9, 751-763.
151. Shen, X.-M., Xia, B., Wrona, M. Z., and Dryhurst, G. (1996) Synthesis, redox properties, in vivo formation, and neurobehavioral effects of N-acetylcysteinyl conjugates of dopamine: Possible metabolites of relevance to Parkinson's disease. Chem. Res. Toxicol. 9, 1117-1126.
152. Shen, X.-M., Zhang, F., and Dryhurst, G. (1997) Oxidation of dopamine in the presence of cysteine: Characterization of new toxic products. Chem. Res. Toxicol. 10, 147-155.
153. Wooley, D. W., and Shaw, E. (1954) A Biochemical and phamacological suggestion about certain mental disorders. Proc. Natl. Acad. Sci. U.S.A. 40, 228-231.
154. Ericksen, N., Martin, G. M., and Benditt, E. P. (1960) Oxidation of the indole nucleus of 5-hydroxytryptamine and the formation of pigments: Isolation and partial characterization of a dimer of 5-hydroxytryptamine. J. Biol. Chem. 235, 1662-1667.
155. Baumgarten, H. G., Bjorklund, A., Lachenmayer, L., Nobin, A., and Stenevi, U. (1971) Long-lasting selective depletion of brain serotonin by 5,6-dihydroxytryptamine. Acta Physiol. Scand. 66, 1-15.
156. Baumgarten, H. G., Evetts, K. D., Holman, R. B., Iverson, L. L., Vogt, M., and Wilson, G. (1972) Effects of 5,6-dihydroxytryptamine on monoaminergic neurones in the central nervous system of the rat. J. Neurochem. 19, 1587-1597.
157. Palmer, A. M., Francis, P. T., Benton, J. S., Sims, N. R., Mann, D. M. A., Neary, D., Snowdon, J. S., and Bowen, D. M. (1987) Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. J. Neurochem. 48, 8-15.
158. Volicer, L., Langlais, P. J., Matson, W. R., Mark, K. A., and Gamache, P. H. (1985) Serotoninergic system in dementia of the Alzheimer type. Abnormal forms of 5-hydroxytryptophan and serotonin in cerebrospinal fluid. Arch. Neural. 42, 1158-1161.
159. Matson, W. R., Langlais, P., Volicer, L., Gamache, P. H., Bird, E., and Mark, K. A. (1984) n-Electrode 3-dimensional chromatography with electrochemical detection for determination of neurotransmitters. Clin. Chem. 30, 1477-1488.
160. Chen, J.-C., Crino, P. B., Schnepper, P. W., To, A. C. S., and Volicer, L. (1989) Increased serotonin efflux by a partially oxidized serotonin: Tryptamine-4,5-dione. J. Pharmacol. Exp. Ther. 250, 141-148.
161. Wolf, W. A., and Bobik, A. (1988) Effects of 5,6-dihydroxytryptamine on the release, synthesis and storage of serotonin: Studies using rat brain synaptosomes. J. Neurochem. 50, 536-542.
162. Slivka, A., Spina, M. B., and Cohen, G. (1987) Reduced and oxidized glutathione in human and monkey brain. Neurosci. Lett. 74, 112-118.
163. Wong, K.-S., and Dryhurst, G. (1990) Tryptamine-4,5-dione: Properties and reaction with glutathione. Bioorg. Chem. 18, 253-264.
164. Singh, S., and Dryhurst, G. (1991) Reactions of the serotonergic neurotoxin 5,6-dihydroxytryptamine with glutathione. J. Org. Chem. 56, 1767-1773.
165. Cohen, G., and Collins, M. A. (1970) Alkaloids from catecholamines in adrenal tissue: Possible role in addiction. Science 167, 1749-1751.
166. Whaley, M. W., and Govindachari, T. R. (1951) The Pictet-Spengler synthesis of tetrahydroisoquinolines and related compounds. In Organic Reactions VI (Rogers, A., Ed.) pp 151-190, John Wiley and Sons, New York.
167. Matsubara, K., Fukishima, S., and Fukui, Y. (1987) A systematic regional study of brain salsolinol levels during and immediately following chronic ethanol injection in rats. Brain Res. 413, 336-343.
168. Fa, Z., and Dryhurst, G. (1991) Interactions of salsolinol with oxidative enzymes. Biochem. Pharmacol. 42, 2209-2219.
169. Davis, V. E., and Walsh, M. J. (1970) Alcohol, amines and alkaloids: A possible biochemical basis for alcohol addiction. Science 167, 1005-1007.
170. Myers, R. D., and Melchior, C. L. (1977) Alcohol drinking: Abnormal intake caused by tetrahydropapaveroline in brain. Science 196, 554-556.
171. Zhang, F., and Dryhurst, G. (1991) Electrochemical and enzymemediated oxidation of tetrahydropapaveroline. J. Org. Chem. 56, 7113-7121.
172. Wallace, L. A. (1989) Major sources of benzene exposure. Environ. Health Perspect. 82, 165-169.
173. Goldstein, B. D. (1977) Hematotoxicity in humans. J. Toxicol. Environ. Health (Suppl. 2), 69-105.
174. Yin, S. N., Li, G. L., Tain, F. D., Fu, Z. I., Jin, C., Chen, Y. J., Luo, S. J., Ye, P. Z., Zhang, J. Z., Wand, G. C., Zhang, X. C., Wu, H. N., and Zhong, Q. C. (1987) Leukemia in benzene workers: A retrospective cohort study: I. General results. Br. J. Ind. Med. 44, 124-128.
175. 3H]benzene. Biochem. Pharmacol. 26, 293-300.
176. Kalf, G. F. (1987) Recent advances in the metabolism and toxicity of benzene. CRC Crit. Rev. Toxicol. 18, 141-159.
177. Tunek, A., Olofssan, T., and Berlin, M. (1981) Toxic effects of benzene and benzene metabolites on granulopoietic stem cells and bone marrow cellularity in mice. Toxicol. Appl. Pharmacol. 59, 149-156.
178. Eastmond, D. A., Smith, M. T., and Irons, R. D. (1987) An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol. Appl. Pharmacol. 91, 85-95.
179. Chen, H., and Eastmond, D. A. (1995) Synergistic increase in chromosomal breakage within the euchromatin induced by an interaction of the benzene metabolites phenol and hydroquinone in mice. Carcinogenesis 16, 1963-1969.
180. Legathe, A., Hoener, B., and Tozer, T. N. (1993) Pharmacokinetic interaction between benzene metabolites, phenol and hydroquinone, in B6C3F1 mice. Toxicol. Appl. Pharmacol. 124,131-138.
181. Subrahmanyam, V. V., Kolachana, P., and Smith, M. T. (1991) Metabolism of hydroquinone by human myeloperoxidase: Mechanisms of stimulation by other phenolic compounds. Arch. Biochem. Biophys. 286, 76-84.
182. Subrahmanyam, V. V., Ross, D., Eastmond, D. A., and Smith, M. T. (1991) Potential role of free radicals in benzene-induced myelotoxicity and leukemia. Free Radical Biol. Med. 11, 495-515.
183. Boersma, G. M., Balvers, W. G., Boeren, S., Vervoot, J., and Rietjens, I. M. C. M. (1994) NADPH-cytochrome reductase catalyzed redox cycling of 1,4-benzoquinone; hampered at physiological conditions, initiated at increased pH values. Biochem. Pharmacol. 47, 1994-1955.
184. Bratton, S. B., Butterworth, M., Lau, S. S., and Monks, T. J. (1997) Identification of quinol-thioethers in bone marrow of hydroquinone/phenol-treated rats and mice and their potential role in benzene-mediated hematotoxicity. Chem. Res. Toxicol. 10, 859-865.
185. Snyder, C. A., Goldstein, B. D., Sellakumar, A., Wolman, S. R., Bromberg, I., Erlichman, M. N., and Laskin, S. (1978) Hematotoxicity of inhaled benzene to Sprague-Dawley rats and AKR mice at 300 ppm. J. Toxicol. Environ. Health 4, 605-618.
186. Zhu, H., Li, Y., and Trush, M. A. (1995) Differences in xenobiotic detoxifying activities between bone marrow stromal cells from mice and rats: Implications for benzene-induced hematotoxicity. J. Toxicol. Environ. Health 46, 183-201.
187. Thomas, D. J., Sadler, A., Subrahmanyam, V. V., Siegel, D., Reasor, M. J., Wierda, D., and Ross, D. (1991) Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: Comparison of macrophages and fibroblastoid cells. Mol. Pharmacol. 37, 255-262.
188. Hill, B. A., Davison, K. L., Dulik, D. M., Monks, T. J., and Lau, S. S. (1994) Metabolism of 2,3,5-(triglutathion-S-yl)hydroquinone in the in situ perfused rat kidney: Relationship to nephrotoxicity. Toxicol. Appl. Pharmacol. 129, 121-132.
189. Kariya, K., Lee, E. W., Hirouchi, M., Hosokawa, M., and Sayo, M. (1987) Purification and some properties of peroxidases of rat bone marrow. Biochem. Biophys. Acta 99, 95-101.
190. Humes, J. L., Bonney, R. J., Pelus, L., Dahlgren, M. E., Sadowski, S. J., Kuehl, F. A., and Davies, P. (1977) Macrophages synthesize and release prostaglandins in response to inflammatory stimuli. Nature (London) 269, 149-151.
191. Kiese, M. (1974) Methemoglobinemia: A Comprehensive Treatise, CRC Press, Boca Raton, FL.
192. Kiese, M., Szinicz, L., Thiel, N., and Weger, N. (1975) Ferrihemoglobin and kidney lesions in rats produced by 4-amino-phenol or 4-dimethylaminophenol. Arch. Toxicol. 34, 337-340.
193. Szinicz, L. L., and Weger, N. (1980) Effects of 4-dimethylaminophenol in rat kidneys, isolated kidney tubules and hepatocytes. Xenobiotica 10, 611-620.
194. Ishikawa, T., Müller, M., Klünemann, C., Schaub, T., and Keppler, D. (1990) ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates. J. Biol. Chem. 265, 19279-19286.
195. Ishikawa, T. (1992) The ATP-dependent glutathione S-conjugate export pump. Trends Biochem. Sci. 17, 463-468,
196. Spector, R., and Johanson C. E. (1989) The mammalian choroid plexus. Sci. Am. 261, 68-74.